Insider Selling: Privia Health Group (NASDAQ:PRVA) CFO Sells $134,025.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 5,361 shares of the stock in a transaction that occurred on Thursday, February 26th. The stock was sold at an average price of $25.00, for a total value of $134,025.00. Following the sale, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at $4,322,725. The trade was a 3.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

David Mountcastle also recently made the following trade(s):

• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The shares were sold at an average price of $25.05, for a total value of $192,809.85.
• On Friday, December 12th, David Mountcastle sold 23,887 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $597,891.61.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $24.30 on Thursday. The stock has a fifty day moving average price of $23.07 and a 200 day moving average price of $23.54. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The company has a market cap of $3.01 billion, a PE ratio of 142.94, a P/E/G ratio of 1.59 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.21. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The company had revenue of $541.17 million for the quarter, compared to analysts’ expectations of $516.61 million. During the same period in the previous year, the company posted $0.21 EPS. Privia Health Group’s revenue was up 17.4% compared to the same quarter last year. Analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds have recently bought and sold shares of the company. Hantz Financial Services Inc. raised its holdings in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares during the last quarter. Global Retirement Partners LLC increased its position in shares of Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after buying an additional 1,351 shares in the last quarter. CWM LLC raised its stake in shares of Privia Health Group by 89.4% during the 2nd quarter. CWM LLC now owns 3,416 shares of the company’s stock worth $79,000 after buying an additional 1,612 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new stake in Privia Health Group in the 4th quarter valued at about $93,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Barclays raised their price objective on shares of Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. raised their price target on Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Wolfe Research set a $31.00 price target on Privia Health Group in a research note on Tuesday, January 6th. Stephens reaffirmed an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a report on Thursday, December 4th. Finally, Citigroup reduced their target price on Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a report on Tuesday. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.00.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.